The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
MOC is a rare histotype of epithelial ovarian cancer, and current management options are inadequate for the treatment of late stage or recurrent disease. A shift towards personalised medicines in ovarian cancer is being observed, with trials targeting specific molecular pathways, however, MOC lags d...
Enregistré dans:
| Auteurs principaux: | Arkan Youssef, Mohammad B. Haskali, Kylie L. Gorringe |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/0791ac7552304fc39602d787ea7987a2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
par: Robert L. Hollis, et autres
Publié: (2021) -
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
par: Wan-Ru Chao, et autres
Publié: (2021) -
Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study
par: Chuanwang Yan, et autres
Publié: (2021) -
An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma
par: Ruben D. Houvast, et autres
Publié: (2021) -
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
par: Melayshia McFadden, et autres
Publié: (2021)